ANGIOTENSIN Drug Patent Profile
✉ Email this page to a colleague
When do Angiotensin patents expire, and when can generic versions of Angiotensin launch?
Angiotensin is a drug marketed by Gland and is included in one NDA.
The generic ingredient in ANGIOTENSIN is angiotensin ii acetate. There are five drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the angiotensin ii acetate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ANGIOTENSIN?
- What are the global sales for ANGIOTENSIN?
- What is Average Wholesale Price for ANGIOTENSIN?
Summary for ANGIOTENSIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | ANGIOTENSIN at DailyMed |
US Patents and Regulatory Information for ANGIOTENSIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gland | ANGIOTENSIN LL ACETATE | angiotensin ii acetate | SOLUTION;INTRAVENOUS | 216966-001 | Jun 3, 2025 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
